Meeting
2013 ASCO Annual Meeting
Comparison of patient performance between PEG/no PEG placement in head and neck cancer patients during chemoradiotherapy treatment.
Authors
Robin Metcalfe-Klaw
Beth Israel Medical Center, New York, NY
Robin Metcalfe-Klaw , Hasan Husaini , Cathy L Lazarus , Louis Benjamin Harrison , Bruce Culliney , Zujun Li , Mark L Urken , Adam Jacobson , Daniel Buchbinder , Mark Persky , Theresa Tran , Michael Pitman , Catherine Concert , Daisy Maria Palacios , Bridget Bennett , Mahesh Kumar , Kenneth Hu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6091)
DOI
10.1200/jco.2013.31.15_suppl.6091
Abstract #
6091
Poster Bd #
16G
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR).
First Author: Marcelo Raul Bonomi
Poster
2019 Supportive Care in Oncology Symposium
Proactive versus reactive feeding tube (FT) placement in head and neck cancer patients (HNC pts) receiving chemoradiation (CRT).
First Author: Thunnisa Sivananth
Poster
2019 Supportive Care in Oncology Symposium
Feasibility of a collaborative palliative and oncology care intervention to improve symptoms and coping during head and neck chemoradiation.
First Author: Jessica Ruth Bauman
Poster
2016 ASCO Annual Meeting
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck.
First Author: Cesar Augusto Perez